{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:18Z","timestamp":1793301138888,"version":"4.5.0"},"reference-count":40,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T00:00:00Z","timestamp":1222128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Objective: Treatment resistance in early onset schizophrenia (EOS) is one of the most challenging problems in child and adolescent psychiatry. We retrospectively examined the therapeutic dosage, clinical response, and side effect profiles of long\u2010term clozapine treatment in Korean children and adolescents with refractory EOS or very early onset schizophrenia (VEOS). Method: 26 refractory patients treated with clozapine for more than 1 year were analyzed. Efficacy was determined by comparing hospitalization rate and duration, before and after clozapine treatment. Tolerability was assessed through review of documented adverse events. Results: A significant reduction in <jats:italic>hospital days per year<\/jats:italic> was observed in 25 (96.2%) patients after clozapine treatment compared to before clozapine. Long\u2010term benefit of the treatment was supported by a further reduction of the hospitalization rate in 14 patients treated with clozapine for more than 3 years. Neutropenia developed in 26.9% patients at 1 year and there was no agranulocytosis. Overall, eight male patients (8\/12, 66.7%) and one female patient (1\/14, 7%) developed neutropenia and out of the nine patients, seven patients were maintained and two patients were successfully rechallenged on clozapine. Conclusion: These findings suggest that long\u2010term clozapine treatment may effectively reduce the amount of time Asian patients with refractory EOS or VEOS spend in the hospital. However careful monitoring of adverse events is required. Copyright \u00a9 2008 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hup.982","type":"journal-article","created":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T15:07:13Z","timestamp":1222182433000},"page":"715-722","source":"Crossref","is-referenced-by-count":26,"title":["Long\u2010term sustained benefits of clozapine treatment in refractory early onset schizophrenia: A retrospective study in Korean children and adolescents"],"prefix":"10.1002","volume":"23","author":[{"given":"Yeni","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boong\u2010Nyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo\u2010Churl","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae\u2010Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min\u2010Sup","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,23]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200505000-00006"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.483"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.5.457"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0318"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(01)00238-X"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.29.10.377"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.273"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e3180ed94e"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199406000-00006"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000171904.23947.54"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.3.459"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.6.5.533"},{"key":"e_1_2_1_15_1","first-page":"62","article-title":"Clozapine in treatment\u2010resistant schizophrenics","volume":"24","author":"Kane JM","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.779"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0609"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm080"},{"key":"e_1_2_1_19_1","first-page":"1245","volume-title":"Pediatrics","author":"Korean Association of Pediatrics","year":"2002"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2005.08.008"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830120020005"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.04.043"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm109"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033495"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620100-00005"},{"key":"e_1_2_1_26_1","first-page":"253","article-title":"Clozapine dosage, serum levels, efficacy, and side\u2010effect profiles: a comparison of Korean\u2010American and Caucasian patients","volume":"32","author":"Matsuda KT","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1192\/S000712500029692X"},{"key":"e_1_2_1_28_1","first-page":"892","article-title":"Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients","volume":"41","author":"Meltzer HY","year":"1990","journal-title":"Hosp Community Psychiatry"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199804001-00003"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.6.576"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200505000-00007"},{"key":"e_1_2_1_32_1","first-page":"89","article-title":"Clozapine reduces rehospitalization among schizophrenia patients","volume":"34","author":"Pollack S","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-006-0553-z"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.7.721"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454603322572697"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e31812eed10"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.842"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.24.12.450"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.170.6.507"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.1021"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721010-00003"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.982","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T16:22:19Z","timestamp":1699978939000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,23]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1002\/hup.982"],"URL":"https:\/\/doi.org\/10.1002\/hup.982","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,23]]}}}